News
BRSYF
13.55
NaN%
--
Brainsway completes revenue-based milestone investment into Axis Integrated
TipRanks · 03/19 12:00
Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change
TipRanks · 03/12 12:20
Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
TipRanks · 03/11 16:00
Brainsway reports Q4 EPS 7c, consensus 3c
TipRanks · 03/11 11:38
Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M
TipRanks · 03/11 11:37
Brainsway announces new data on noninvasive way to treat depression
TipRanks · 03/04 12:50
Brainsway announces new minority-stake investment in BrainStim Health
TipRanks · 02/19 12:40
Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS
TipRanks · 02/18 12:35
BrainsWay to change in ADS ratio to 1-for-1, effective March 3
Seeking Alpha · 02/17 12:54
Brainsway management to meet virtually with Northland
TipRanks · 02/10 20:10
Are Biotech And Pharma Stocks Poised To Keep Climbing After Hitting 52-Week Highs?
NASDAQ · 01/27 10:34
Brainsway price target raised to $30 from $24 at H.C. Wainwright
TipRanks · 01/26 11:11
Brainsway price target raised to $30 from $23 at Northland
TipRanks · 01/22 14:06
Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system
TipRanks · 01/12 12:47
Brainsway announces first coverage policy for accelerated Deep TMS
TipRanks · 01/07 12:37
Northland Securities Reaffirms Their Buy Rating on Brainsway (BWAY)
TipRanks · 12/23/2025 14:25
Brainsway announces Optum Behavioral expanded policy applicable to Deep TMS
TipRanks · 12/22/2025 12:35
Brainsway launches first trial of Deep TMS 360 system for AUD
TipRanks · 11/17/2025 12:46
Brainsway’s Market Expansion and Strong Revenue Performance Justify Buy Rating
TipRanks · 11/13/2025 15:45
Brainsway price target raised to $18 from $17 at H.C. Wainwright
TipRanks · 11/13/2025 15:35
More
Webull provides a variety of real-time BRSYF stock news. You can receive the latest news about Brainsway through multiple platforms. This information may help you make smarter investment decisions.
About BRSYF
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.